Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

STEP perspective

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
STEP Perspective|July 1, 1995
Tuberculosis and HIV infectionN Rolfsen
STEP Perspective|July 1, 1995
Disseminated MAC: current treatment strategiesT Ferreira
STEP Perspective|January 1, 1995
Oral ganciclovirJ T Schouten
STEP Perspective|April 1, 1996
Current HIV treatment strategiesT Ferreira
STEP Perspective|April 1, 1996
New drug recommended for treatment of CMV retinitisJ M Bray
STEP Perspective|July 1, 1996
Opportunistic disease and other condition studies open for enrollment--August 1996. University of Washington AIDS Clinical Trials Unit
STEP Perspective|January 1, 1997
Immune modulation with IL-2 and IL-12L Boonprakong
STEP Perspective|May 22, 2001
Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan DawsonR Moss
STEP Perspective|May 22, 2001
Ask Dr. JeffJ Schouten
STEP Perspective|May 22, 2001
Improving HAART naturallyB S Lichtenstein
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
STEP Perspective|July 1, 1995
Tuberculosis and HIV infectionN Rolfsen
STEP Perspective|July 1, 1995
Disseminated MAC: current treatment strategiesT Ferreira
STEP Perspective|January 1, 1995
Oral ganciclovirJ T Schouten
STEP Perspective|April 1, 1996
Current HIV treatment strategiesT Ferreira
STEP Perspective|April 1, 1996
New drug recommended for treatment of CMV retinitisJ M Bray
STEP Perspective|July 1, 1996
Opportunistic disease and other condition studies open for enrollment--August 1996. University of Washington AIDS Clinical Trials Unit
STEP Perspective|January 1, 1997
Immune modulation with IL-2 and IL-12L Boonprakong
STEP Perspective|May 22, 2001
Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan DawsonR Moss
STEP Perspective|May 22, 2001
Ask Dr. JeffJ Schouten
STEP Perspective|May 22, 2001
Improving HAART naturallyB S Lichtenstein
Pageof 10